Physicians and patients measure different dimension on assessment for gatroesophageal reflux disease-related symptoms

Journal of Neurogastroenterology and Motility

Volumn 17, Issue 4, 2011, Pages 381-386

  Lopez Alvarenga, Juan Carlos ^a,c,d   Sobrino Cossio, Sergio ^b   Fass, Ronnie ^e   Vargas Romero, Jose A ^c  

^a SECRETARÍA DE SALUD   (Mexico)

^b INSTITUTO NACIONAL DE CANCEROLOGÍA   (Mexico)

^c Nycomed Mexico SA de CV   (Mexico)

^d SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH   (United States)

^e SOUTHERN ARIZONA VA HEALTH CARE SYSTEM   (United States)

Author keywords

Monitoring; Pantoprazole; Physiologic; Questionnaires

Indexed keywords

EID: 80054946616     PISSN: 20930879     EISSN: 20930887     Source Type: Journal    
DOI: 10.5056/jnm.2011.17.4.381     Document Type: Article

References (10)

1. Stanghellini V, Armstrong D, Mönnikes H, Bardhan KD. Systematic review: Do we need a new gastro-oesophageal reflux disease questionnaire? Aliment Pharmacol Ther 2004;19:463-479.
2. Netinatsunton N, Attasaranya S, Ovartlarnporn B, Sangnil S, Boonviriya S, Piratvisuth T. The Value of Carlsson-dent questionnaire in diagnosis of gastroesophageal reflux disease in area with low prevalence of gastroesophageal reflux disease. J Neurogastroenterol Motil 2011;17:164-168.
3. Irvine EJ, Feagan BG, Wong CJ. Does self-administration of a quality of life index for inflammatory bowel disease change the results? J Clin Epidemiol 1996;49:1177-1185.
4. Locke GR, Talley NJ, Weaver AL, Zinsmeister AR. A new questionnaire for gastroesophageal reflux disease. Mayo Clin Proc 1994; 69:539-547.
5. Moreno Elola-Olaso C, Rey E, Rodríguez-Artalejo F, Locke GR 3rd, Díaz-Rubio M. Adaptation and validation of a gastroesophageal reflux questionnaire for use on a Spanish population. Rev Esp Enferm Dig 2002;94:745-758.
6. Lopez-Colombo A, Lopez-Alvarenga JC, Vargas J, et al. Do prior pregnancies modify the intensity of symptoms related to GERD? A report of the Mexican GERD working group. Gut 2008;57(suppl 2):A312.
7. Lopez L, Lopez-Alvarenga JC, Comuzzie AG, Gonzalez J, Crespo Y, Vargas J. Nighttime GERD symptoms associated with dyspepsia, esophageal discomfort, and extraesophageal complaints improvement after treatment with Pantoprazole magnesium; 40 mg daily for 28 days. Gastroenterology 2008;134(suppl 1):A176-A177.
8. Mönnikes H, Bardhan KD, Stanghellini V, Berghöfer P, Bethke TD, Armstrong D. Evaluation of GERD symptoms during therapy. Part II. Psychometric evaluation and validation of the new questionnaire ReQuest in erosive GERD. Digestion 2004;69:238-244.
9. Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika 1951;16:297-334.
10. Brandt LJ, Bjorkman D, Fennerty MB, et al. Systematic review on the management of irritable bowel syndrome in North America. Am J Gastroenterol 2002;97(11 suppl):S7-S26.